20 / 154
Speaker’s Biographies
Florian Scotté
European Hospital Georges Pompidou, Paris, France
Florian Scotté is MD-PhD and medical oncologist at the European Hospital Georges Pompidou (Paris, France), and head
of the SCUPP (Supportive Care in Cancer Unit Pompidou Paris).
He is member of the ESMO, MASCC (Multinational Association for Supportive Care in Cancer), the ASCO, CKIN
5cancer and the Kidney International Network) and is General Secretary of the AFSOS (French Speaking Association
for Supportive Care in Cancer).
Teaching at several universities, and Coordinator of the inter-university diploma of supportive care, he is involved in
training both medical and para-medical.
He is also the coordinator and co-investigator of numerous studies especially in supportive care: GTP 001, the effectiveness
of a glove refrigerant preventing onycholysis, AESCO 001, the effectiveness of a liner refrigerant prevention of skin and
nail toxicities, AESCO 002, the effectiveness of a cooling jacket on the hands and feet in the prevention of hand foot
syndrome, but also analysis of the requirements of recombinant erythropoietin in oncology. He recently published data
on supportive care status in France and new organisation in ambulatory chemotherapy administration.
He also serves on the editorial board of Elsevier Quality of Life Website and « La Lettre du Cancérologue » and coordinate
« news on line » programs during international meetings on
lecancer.frwebsite.
Speaker Abstract(s): S53, S54
Ponnandai Somasundar
Boston University, Surgery, Providence, Rhode Island, USA
Ponnandai Somasundar MD is a surgical oncologist with interest in GI cancers with an expertise in minimally invasive
surgery. He is an Associate Professor of Surgery in Boston University and Associate Chief of Surgical Oncology in Roger
Williams Medical Center. He is also the Director of Geriatric Oncology Program with a special interest in taking care of
the elderly with cancer. He runs the geriatric oncology program in his institution. He is well published in multiple peer
reviewed journals. He is a member of multiple national and international surgical organizations and actively participates
in them.
Speaker Abstract(s): S55
Pierre Soubeyran
Université de Bordeaux, Medical Oncology, Bordeaux, France
Pierre Soubeyran, M.D., Ph.D., is a Medical Oncologist at Institut Bergonié, Comprehensive Cancer Center in Bordeaux,
and Professor of Medical Oncology at the University of Bordeaux. He is highly involved in the development of Geriatric
Oncology at both the clinical (co-coordinator of the Coordination Unit of Geriatric Oncology of Aquitaine) and research level
(President of the Scientific Council of the French Society of Geriatric Oncology (SoFOG) and Coordinator of the French
Geriatric Oncology Cooperative Group DIALOG). He is also involved in cancer research as Director of Research of Institut
Bergonié comprehensive cancer center in Bordeaux, Director of the U1218 INSERM Cancer research unit and Director of
the SIRIC, Center for Integrated Cancer Research of Bordeaux, named BRIO (Bordeaux Recherche Intégrée Oncologie).
He earned his Medical Degree from the University of Nantes in France and trained in Medical Oncology at the Institut
Bergonié and University of Bordeaux. He completed a fellowship at the MD Anderson Cancer Center in Houston and later
obtained his Ph.D. at the University of Bordeaux in the field of minimal residual disease in follicular lymphoma. An active
researcher, Prof. Pierre Soubeyran’s clinical interests include clinical and biological research on lymphoma and geriatric
oncology. He is leading trials focused on these topics as part of the French LYSA lymphoma Research Group and the
French Geriatric Oncology Cooperative Group DIALOG. He is a member of ESMO, ASCO, ASH, SoFOG and SIOG. He
has authored and co-authored numerous articles, book chapters and monographs on various aspects of cancer treatment.
Speaker Abstract(s): S57, S58, S59
Reinhard Stauder
Medical University Innsbruck
,
Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria
Reinhard Stauder received his Doctoral Degree in Medicine in 1981 from the University of Innsbruck and in 2006 received
a Master’s Degree in Health Sciences from the University of Health Sciences, Medical Informatics and Technology, Hall
in Tirol, Austria. From 1994–1996, he was Scientific Member at the Basel Institute for Immunology, Basel, Switzerland.
RS is a specialist in Internal Medicine, a Certified Specialist in Hematology and Oncology and Associate Professor
of Medicine at Innsbruck Medical University, Austria. His main clinical and scientific focus lies in Myelodysplastic
Syndromes (MDS), in geriatric oncology and in anemia in the elderly. His main goal is the development of individualized
treatment algorithms in elderly cancer patients.
At present RS is responsible for the geriatric oncology and MDS program of the Department of Internal Medicine V
(Haematology and Oncology), Innsbruck Medical University. RS is a member of the European Leukemia Net (ELN) and
is representative of Austria in the European LeukemiaNet MDS registry (EU-MDS). RS is a member of the board of
the Austrian Society for Haematology and Oncology (OEGHO) as well as vice-chairman of the Austrian MDS-Plattform
and chairman of the Geriatric Oncology Group of the OEGHO. RS is the National Representative for Austria in the